Patent application number | Description | Published |
20110028434 | LONG-CHAIN POLYUNSATURATED FATTY ACIDS (LC-PUFA) IN MATERNAL NUTRITION DURING PREGNANCY AND LACTATION - The present invention relates in general to maternal food compositions. In particular, the present invention relates to maternal food compositions comprising LC-PUFA and their uses. Embodiments of the present invention relate to maternal food compositions comprising a source of lipids, wherein the source of lipids includes at least one LC-PUFA in the form selected from the group consisting of phospholipids (PL), phosphotidylcholine (PC), phosphatidylethanolamine (PE), N-Acylphosphatidylethanolamine (NAPE), phosphatidylinositol (Pl), phosphatidylserine (PS) or their lyso derivatives and their uses in brain development and eye development of neonates. | 02-03-2011 |
20110165198 | METHOD FOR REDUCING LIPID ABSORPTION BY AN ANIMAL - The invention provides methods for using fatty acid alkanolamides for reducing lipid absorption from the intestine of an animal. Reducing lipid absorption results in fewer lipids available for an animal to convert to body fat. Converting fewer lipids to body fat means that the animal reduces body fat, body weight, and/or body weight gain when consuming an equivalent amount of lipids without the fatty acid alkanolamides. | 07-07-2011 |
20110196042 | COMPOSITIONS AND METHODS FOR INFLUENCING SATIETY, LIPID METABOLISM, AND FAT UTILIZATION - The invention provides (1) genes differentially expressed in animals administered fatty acid amides that affect one or more of food intake, satiety, lipid metabolism, and fat utilization and (2) compositions and methods relating to the use of the genes to identify new compounds that affect one or more of food intake, satiety, lipid metabolism, and fat utilization. | 08-11-2011 |
20110313039 | METHOD FOR INCREASING ENDOGENOUS PLASMALOGEN LEVELS IN MAMMALS - The present invention relates generally to compounds such as alkylglycerol and alkoxyglycerol for use in increasing the endogenous level of plasmalogens in a mammal. In particular, these compounds are used for increasing the endogenous plasmalogen level to a level greater than the level in healthy mammals. According to the present invention such compounds are also for use in the prevention or treatment of diseases caused or affected by a decreased endogenous level of plasmalogens. A method for the manufacture of a dietary precursor for the use of the present invention is also part of the present disclosure. | 12-22-2011 |
20120171177 | NUTRITIONAL COMPOSITION FOR SUPPORTING BRAIN DEVELOPMENT AND FUNCTION OF TODDLERS - The present invention relates to a nutritional composition, in particular directed to toddlers and/or a weaning child, said nutritional composition comprising a protein source, a source of available carbohydrates, a lipid source, at least one probiotic microorganism, and prebiotics, wherein said lipid source comprises DHA (docosahexaenoic acid). The nutritional composition improves cognitive performance, in particular learning and memory of the child. Preferably, the composition comprises iron, zinc, vitamin D and/or sialic acid. Preferably, the composition comprises a source of phospholipids rich in DHA. | 07-05-2012 |
20130109753 | SN-2-MONOACYLGLYCEROLS AND LIPID MALABSORPTION | 05-02-2013 |
20140018560 | PRODUCING REFINED PLANT OILS FROM WASHED CRUDE PLANT OIL - The present invention generally relates to the field of refined oils. In particular, the present invention relates to refined plant oils substantially free of chlorinated contaminants, such as monochloropropanediol (MCPD), in particular 3-MCPD di-esters, and to a process to produce such oils. To achieve this, crude oil is liquid-liquid extracted to remove chlorine donors before it is further refined. | 01-16-2014 |
20140018561 | REFINED PLANT OILS FREE OF GLYCIDYL ESTERS - The present invention generally relates to the field of oil refinement. In particular, the present invention relates to the field of processes to produce refined oils, substantially free of contaminants, such as glycidyl esters, for example. In accordance with the present invention, such refined plant oils free of glycidyl esters may be obtained by using plant oil or a plant oil fractions having a maximum level of 3 weight-% diacylglycerols (DAG) in the oil refinement process. | 01-16-2014 |
20140018562 | PLANT OIL REFINEMENT IN THE PRESENCE OF ALCOHOL - The present invention generally relates to the field of refined oils. In particular, the present invention relates to refined plant oils substantially free of chlorinated contaminants, such as monochloropropanediol (MCPD), in particular 3-MCPD di-esters, and to a process to produce such oils. To achieve this, at least one alcohol is added to the oil during refinement. | 01-16-2014 |
20140031426 | SN-1(3) MONOACYLGLYCERIDES AND LIPID ABSORPTION - The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising sn-1(3) monoacylglycerols, wherein the sn-1 or sn-3 position is occupied by an acyl group such as a fatty acid and the sn-2 position remains unoccupied. The fatty acid may be one with anti-inflammatory properties. | 01-30-2014 |
20140142169 | SN-2-MONOACYLGLYCEROLS AND LIPID MALABSORPTION - The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising a sn-2 monoacylglycerol derivative, wherein the sn-1 and sn-3 positions are blocked by protective groups. The acyl group may be a fatty acid, for example one with anti-inflammatory properties. | 05-22-2014 |
20140186454 | DHA AND EPA IN THE REDUCTION OF OXIDATIVE STRESS - The present invention generally relates to the prevention or treatment of disorders related to oxidative stress. For example, the present invention provides a composition for use in the prevention or treatment of oxidative stress related disorders under post-operative conditions. One embodiment of the present invention is a composition comprising DHA and EPA as active ingredients for use in the treatment or prevention of oxidative stress and/or related disorders. | 07-03-2014 |
20140322187 | MONOUNSATURATED FATTY ACID FOR NAILCARE - The invention relates to the cosmetic use of an effective amount of at least one monounsaturated fatty acid, of a salt thereof and/or of an ester thereof, as a nailcare active agent. | 10-30-2014 |